Skip to content

Physical Activity in Bed Rest Hospitalized High-Risk Pregnant Women.

Physical Activity in Bed Rest Hospitalized High-Risk Pregnant Women

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07657000
Acronym
BedRest-1
Enrollment
140
Registered
2026-06-18
Start date
2026-09-01
Completion date
2029-09-01
Last updated
2026-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bed Rest, Pregnancy, Pregnancy Complications

Keywords

Bed rest, Pregnancy, Pregnancy complications, Hospitalization, Exercise, Exercise adaptations

Brief summary

This study aims to evaluate the impact of a specifically designed exercise program for hospitalized high-risk pregnant individuals on bed rest. This is a specifically designed physical activiity program, consisting of a resistance and strength exercises intended to be performed even while in bed and seeks to address physical and emotional health challenges during hospitalization. The study will compare outcomes between participants who follow the exercise program and those receiving standard care. Primary outcomes include physical and emotional health parameters, quality of life, and sleep quality. Secondary outcomes focus on feasibility, adherence, and participant satisfaction. This research addresses the gap in physical activity guidelines for pregnant individuals on bed rest and explores the potential benefits of exercise to improve maternal well-being and postpartum recovery.

Detailed description

This study investigates the feasibility and potential benefits of a specifically designed exercise program for hospitalized high-risk pregnant individuals on bed rest. The program includes resistance and strength exercises tailored to be safely performed while in bed, aiming to counteract the physiological and psychological deconditioning associated with prolonged inactivity during hospitalization. Prolonged bed rest during pregnancy, often prescribed for high-risk conditions, can result in muscle atrophy, reduced cardiovascular capacity, and psychological distress, including anxiety, stress, and depression. Despite the known adverse effects of inactivity, there is limited evidence on structured exercise programs for this population. This study seeks to fill that gap by testing an intervention designed to mitigate these negative outcomes. Participants will be randomized into two groups: an exercise group (EG) and a no-exercise group (NEG). The EG will perform daily supervised exercises, lasting approximately 30 minutes, under the guidance of trained staff. The NEG will follow standard care without structured physical activity. The study evaluates physical health parameters (e.g., activity levels, muscle strength), mental health outcomes (e.g., anxiety, depression, stress), sleep quality, and quality of life. Secondary objectives include assessing program feasibility, recruitment rates, adherence, and participant satisfaction. Data collection will include validated self-reported questionnaires, wearable devices (accelerometers), and clinical measures. Key endpoints will be compared between groups at regular intervals during hospitalization and at six weeks postpartum. This pilot randomized controlled trial aims to generate knowledge on the acceptability, safety, and preliminary effectiveness of bed-rest exercise programs in high-risk pregnancies, with the goal of informing future larger-scale studies and addressing an unmet need in maternal care.

Interventions

OTHERExercise

Specifically designed and structured exercise program (based on resistance/strength, designed to be executed in bed or minimal mobility). It is an adaptation from the exercise program described by Brun CR et al (Brun CR, Shoemaker JK, Bocking A, Hammond JA, Poole M, Mottola MF. Bed-rest exercise, activity restriction, and high-risk pregnancies: a feasibility study. Applied Physiology, Nutrition, and Metabolism. 2011;36(4):577-582).

Sponsors

Hospital Clinic of Barcelona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This study follows a parallel assignment model, where participants are randomized into two distinct groups. One group will follow a specifically designed exercise program tailored for individuals on bed rest during high-risk pregnancy, while the other group will receive standard care without structured physical activity. The intervention group will perform daily resistance and strength exercises adapted for execution while in bed. The control group will serve as a comparison to evaluate the impact of the exercise program on physical and emotional health, quality of life, and sleep during hospitalization. Randomization ensures unbiased allocation, and both groups will be monitored simultaneously throughout the study duration.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Maternal age of 18 or more * Delivery not expected within 1 week after recruitment. * Language ability to understand the study. * Informed consent signed.

Exclusion criteria

* Fetal death * Severe mental health disorders and substance abuse disorders.

Design outcomes

Primary

MeasureTime frameDescription
Physiological parameters: Rectus femoris area measurementBaseline, weeks 1, 2, 3, 4, 5 to 6 after enrolment, within 24h after delivery and 6 weeks postpartumLoss of rectus femoris area (cm2) in a relaxed state, assessed by ultrasound
Physiological parameters: Time spent in moderate or vigorous activityBaseline, weeks 1, 2, 3, 4, 5 to 6 after enrolment, within 24h after delivery and 6 weeks postpartumTime spent in moderate or vigorous activity (in minutes, summarized as average per day).
Physiological parameters: Total physical activityBaseline, weeks 1, 2, 3, 4, 5 to 6 after enrolment, within 24h after delivery and 6 weeks postpartumTotal physical activity (average per day in mG).
Physiological parameters: Handgrip strength test.Baseline, weeks 1, 2, 3, 4, 5 to 6 after enrolment, within 24h after delivery and 6 weeks postpartumHandgrip strength test (in kg, adjusted for gender and age).
Mental health/emotional parameters: GAD-7Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartumGAD-7: Generalized Anxiety Disorder assessment scale (score ranging from 0 to 21). The higher the results, higher is the severity of anxiety.
Mental health/emotional parameters: Perceived Stress Scale (PSS-10)Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartumPerceived Stress Scale (PSS-10) (score ranging from 0 to 40). The higher the results, higher is the perception of stress.
Mental health/emotional parameters: Edinburg Postpartum Depression ScaleBaseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartumEdinburg Postpartum Depression Scale (EPDS) (score -ranging from 0 to 30- and percentage of score ≥9). The higher the total score, more intense is the emotional stress.
Sleep cycle and Quality of life parameters: Sleep average per nightBaseline, 2, 4 and 6 weeks after enrolment, whitin 24h after deliverySleep average per night (in minutes)
Sleep cycle and Quality of life parameters: WHOQOL-BREF scoreBaseline, 2, 4 and 6 weeks after enrolment, whitin 24h after deliveryAbbreviated version of the World Health Organization Quality of Life Assessment scale (WHOQOL-BREF) (score ranging from 0 to 100). The higher the score, better is the perception of quality of life.
Mental health/emotional parameters: SAM: The Self-Assessment ManikinDailyVisual standardized measure of emotional tone that covers 3 different affective domains (valence, arousal and sense of control). Responses are made by selecting the manikin that best represents the emotional state of the patient. The patient selection is afterwards converted into a numerical result with higher scores indicating more positive affective tone.
Mental health/emotional parameters: RRS: The Ruminative Response ScaleBaseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartum10-item questionnaire intended to measure rumination, tendency to worriedness and repetitive thinking in front of stressful situations. (score ranking from 10 to 40). Higher scores indicate a higher tendeny to ruminate and a vulnerability trait to psychological distress
Mental health/emotional parameters: BDI-II:Baseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartumQuestionnaire to measuring depression at a cognitive, affective and behavioral level. For the present study only 4 items related to hedonic experience will be selected. Higher scores in each item indicate severity in the loss of hedonic capacity. Reponses are made by using a 4-point Likert scale.
Physiological parameters: Muscle UltrasoundBaseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartumMuscle ultrasound will be conducted weekly by blinded sonographers using a linear probe (7.5 - 10 MHz). All images will be acquired in triplicate, and the average value will be used for analysis.
Physiological parameters: Maternal Cardiac UltrasoundBaseline, 2, 4 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartumTransthoracic echocardiography will be performed using standardised imaging protocols. All measurements will be performed in triplicate when feasible, and averaged for analysis. Standardization of acquisition settings and operator blinding to clinical data will be ensured to reduce measurement bias.
Feasibility evaluation of the implementation of the exercise program: Time needed to recruit sample sizeThrough study completion, an average of 6 monthsTime needed to recruit sample size (in days)
Feasibility evaluation of the implementation of the exercise program: Number of women who declined to participate in the studyThrough study completion, an average of 6 monthsNumber of women who declined to participate in the study
Feasibility evaluation of the implementation of the exercise program: Number of women who give up participation in the studyThrough study completion, an average of 6 monthsNumber of women who give up participation in the study
Feasibility evaluation of the implementation of the exercise program: Adherence to the programThrough study completion, an average of 6 monthsAdherence to the program (number of days of actual performance of the exercise program while admitted)
Satisfaction evaluationAt deliveryA questionnaire made specifically for the case evaluating different domains (length of the sessions, hardness of the sessions, daily repetition of the sessions, difficulty in particular exercises, willingness to repeat in case of re-admission, overall satisfaction to be included in the program) - Likert scale (1 to 5, being 1 not satisfied at all, and 5 highly satisfied).

Secondary

MeasureTime frameDescription
Baseline Maternal and fetal characteristics: Evaluation of physical activity (GAQ-P questionnaire)BaselineThe questionnarie self-clasisfies how often and for how long the participant engages in light-, moderate-, or vigorous-intensity physical activity. It also assesses whether the participant should consult her obstetric health care provider before beginning or continuing physical activity during pregnancy. The GAQP is a screening and classification tool and does not generate a numerical summary score. Therefore, no minimun or maximum applies, and higher or lower scores do not indicate a better or worse outcome.
Baseline Maternal and fetal characteristics: Maternal ageBaselineMaternal age (In years)
Baseline Maternal and fetal characteristics: Maternal weightBaselineMaternal weight (In kg)
Baseline Maternal and fetal characteristics: Ethnic groupBaselineEthnic group classified as: - White/European - Hispanic/latin American - Black/African Americans - Arabic - Asian
Baseline Maternal and fetal characteristics: Gestational age at recruitmentBaselineGestational age at recruitment (in weeks + days)
Baseline Maternal and fetal characteristics: Twin pregnancyBaselineTwin pregnancy (yes/no)
Baseline Maternal and fetal characteristics: Fetal growth percentile at admissionBaselineFetal growth percentile at admission (customized for gender and multiplicity)
Baseline Maternal and fetal characteristics: Medical condition that justifies hospital admissionBaselineMedical condition that justifies hospital admission (hypertensive disorders, preterm labor, rupture of membranes, antepartum bleeding, others)
Baseline Maternal and fetal characteristics: Musculoskeletal limitationsBaselineMusculoskeletal limitations (injuries or pathologies) (yes/no and description)
Maternal and fetal characteristics during hospital admission: Medication while admittedBaseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartumMedication while admitted (antihypertensive treatment, tocolysis, magnesium sulphate, antibiotics, corticosteroids, others)
Maternal and fetal characteristics during hospital admission: Length of stay in the intermediate care unitBaseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartumLength of stay in the intermediate care unit (in days)
Maternal and fetal characteristics during hospital admission: Length of hospital admissionBaseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartumLength of hospital admission (in days)
Maternal and fetal characteristics during hospital admission: Fetal CTGBaseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartumFetal CTG description
Maternal and fetal characteristics during hospital admission: Diet during the admissionBaseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartumDiet during the admission (in Kcal and special needs)
Maternal and fetal characteristics during hospital admission: Daily fluid intakeBaseline, 1, 2, 3, 4, 5 and 6 weeks after enrolment, whitin 24h after delivery and 6 weeks postpartumDaily fluid intake (in mL)
Perinatal outcomes: Gestational age at deliveryWhitin 24h after delivery and 6 weeks postpartumGestational age at delivery (in weeks + days
Perinatal outcomes: BirthweightWhitin 24h after delivery and 6 weeks postpartumBirthweight (in grams) and percentile
Perinatal outcomes: SGA/growth restrictionWhitin 24h after delivery and 6 weeks postpartumSGA/growth restriction (yes/no) and classification, if any
Perinatal outcomes: Mode of deliveryWhitin 24h after delivery and 6 weeks postpartumMode of delivery (spontaneous, assisted, cesarean section)
Perinatal outcomes: Composite adverse maternal outcomeWhitin 24h after delivery and 6 weeks postpartumComposite adverse maternal outcome (yes/no considering any of the following: re-intervention, endometritis, infection of surgical wound, curettage, admission to intensive care unit, hysterectomy, need for transfusion, postpartum hemorrhage requiring medication other than oxytocin or ergometrine, maternal sepsis, death)
Perinatal outcomes: Neonatal admission to neonatal intensive care unitWhitin 24h after delivery and 6 weeks postpartumNeonatal admission to neonatal intensive care unit (yes/no)
Perinatal outcomes: Composite adverse neonatal outcomeWhitin 24h after delivery and 6 weeks postpartumComposite adverse neonatal outcome: (yes/no considering any of the following: respiratory morbidity - respiratory distress syndrome or transient tachypnea - requiring intubation, moderate-severe bronchopulmonary dysplasia, intraventricular hemorrhage grade III-IV, early-onset sepsis, periventricular leukomalacia, necrotizing enterocolitis, retinopathy requiring laser, fetal or neonatal death)
Perinatal outcomes: Breastfeeding ratesWhitin 24h after delivery and 6 weeks postpartumBreastfeeding rates

Countries

Spain

Contacts

CONTACTFederico Migliorelli, Migliorelli, MD, PhD
secmmf@clinic.cat+34932275400
CONTACTMontse Palacio, MD, PhD
secmmf@clinic.cat+34932275400
PRINCIPAL_INVESTIGATORFederico Migliorelli, MD, PhD

Gynecologist especialist on Maternal fetal medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 19, 2026